Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2013-08-09Clinical Trial Update: Monitoring and Outcome Measures in Asthmatics and Smokers During Pregnancy
A clinical trial sponsored by the University of Kentucky examining monitoring and outcome measures in pregnant individuals with asthma and t…
-
CLINICAL_TRIALS withdrawal · 2013-08-09Clinical Trial Update: Oral Contraceptives and Asthma Control
A clinical trial investigating the effect of oral contraceptives on asthma control has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-08-08Clinical Trial Update: Study HZA106829: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics [Phase 3]
This ClinicalTrials.gov update reports the results of a Phase 3 efficacy and safety study evaluating the inhaled combination fluticasone fur…
-
CLINICAL_TRIALS trial_result · 2013-08-08Clinical Trial Update: Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents [Phase 3]
A Phase 3 trial assessed the efficacy and safety of Fluticasone furoate inhalation powder for asthma in adults and adolescents; the study ha…
-
CLINICAL_TRIALS trial_result · 2013-08-08Clinical Trial Update: Safety Study of the Effects of Inhaled Fluticasone Furoate/GW642444 on the Hypothalamic-Pituitary-Adrenal (HPA) Axis [Phase 3]
Phase 3 safety trial evaluating whether inhaled fluticasone furoate with GW642444 affects the hypothalamic-pituitary-adrenal axis in asthma …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-08-07Clinical Trial Update: Efficacy and Safety Study in Subjects With Asthma [Phase 2]
This update summarizes efficacy and safety results from a Phase 2 asthma trial sponsored by GlaxoSmithKline. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2013-08-07Clinical Trial Update: Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of Asthma [Phase 2]
Phase 2 trial assessing GW685698X, an inhaled corticosteroid, in asthma reports safety and efficacy for both once-daily and twice-daily dosi…
-
CLINICAL_TRIALS research · 2013-08-07Clinical Trial Update: Implementation of an Asthma Program to Improve Asthma Identification and Education in Children
This clinical trial update describes the implementation of an asthma identification and education program in children to improve recognition…
-
FDA approval · 2013-08-06FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Montelukast Sodium from Dr. Reddy's Laboratories Limited under an ANDA.
-
FDA approval · 2013-08-06FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Montelukast Sodium submitted by Dr. Reddy's Laboratories Limited.
-
CLINICAL_TRIALS trial_result · 2013-08-05Clinical Trial Update: Real-world Effectiveness and Cost-effectiveness of Qvar Versus FP, a US Study
A real-world US study comparing the effectiveness and cost-effectiveness of Qvar (beclomethasone dipropionate) versus Flovent (fluticasone p…
-
CLINICAL_TRIALS trial_result · 2013-07-31Clinical Trial Update: Efficacy and Safety of 2 Doses of Tiotropium Via Respimat in Adult Patients With Mild Persistent Asthma [Phase 3]
This Phase 3 trial evaluated the efficacy and safety of two doses of tiotropium delivered by Respimat in adults with mild persistent asthma.…
-
CLINICAL_TRIALS trial_result · 2013-07-31Clinical Trial Update: Study to Evaluate the Effects of Weight Loss on Airway Inflammation and Mechanics in Subjects With Asthma (Asthma-Bariatric Surgery Study)
This completed clinical trial evaluated the impact of weight loss on airway inflammation and mechanics in individuals with asthma, in the As…
-
FDA approval · 2013-07-30FDA Approved: DULERA — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Dulera (mometasone furoate and formoterol fumarate dihydrate) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics [Phase 3]
A Phase 3 study assessing efficacy and safety of fluticasone furoate/vilanterol (GW642444) in adults and adolescents with asthma completed w…
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: Effects of Lipoic Acid on Oxidative, Inflammatory and Functional Markers in Asthmatic Patients [NA]
A completed clinical trial assessed the effects of alpha-lipoic acid on oxidative, inflammatory, and functional markers in asthmatic patient…
-
CLINICAL_TRIALS trial_result · 2013-07-29Clinical Trial Update: Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212) [Phase 3]
Phase 3 trial update on mometasone furoate/formoterol fumarate (Dulera) inhaler for persistent asthma in adolescents and adults; results pos…
-
CLINICAL_TRIALS trial_result · 2013-07-25Clinical Trial Update: Real-world Effectiveness of Combination Therapies in Primary Care Asthma Management
The study reports on the real-world effectiveness of combination therapies for managing asthma in primary care, based on completed trial dat…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2) [Phase 2]
Phase 2 trial evaluating the bronchodilator effect of a mometasone furoate/formoterol fumarate combination inhaler in children with persiste…
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: Role of TLR4 in Environmental Asthma [Phase 1]
A Phase 1 trial investigating the role of TLR4 in environmental asthma has completed.
-
CLINICAL_TRIALS research · 2013-07-16Clinical Trial Update: Nitric Oxide, LPS and the Pathogenesis of Asthma Phase II [Phase 1]
The trial investigating nitric oxide and lipopolysaccharide in the pathogenesis of asthma in healthy volunteers was terminated.
-
CLINICAL_TRIALS trial_result · 2013-07-15Clinical Trial Update: 4-Week Study of Efficacy, Safety and PK of Albuterol-HFA Versus Proventil-HFA in Pediatric Asthma [Phase 3]
Phase 3 pediatric trial comparing Albuterol-HFA with Proventil-HFA was terminated; the update notes a 4-week study focusing on efficacy, saf…
-
CLINICAL_TRIALS trial_result · 2013-07-15Clinical Trial Update: Controlled, 12-Week Study of Albuterol HFA Versus the Active Control, Proventil(R)-HFA in Asthmatic Patients [Phase 3]
A Phase 3 trial comparing Albuterol HFA to Proventil-HFA in asthmatic patients was terminated.
-
CLINICAL_TRIALS trial_result · 2013-07-15Clinical Trial Update: Single-Dose Cross-Over Study of the Effects of Albuterol-HFA in Exercise Induced Bronchoconstriction [Phase 3]
Phase 3 cross-over study evaluating albuterol HFA for exercise-induced bronchoconstriction was terminated.
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: An Efficacy and Safety Evaluation of Tiotropium add-on Therapy in Patients With Severe Persistent Asthma [Phase 2]
Phase 2 trial evaluating tiotropium as add-on therapy in severe persistent asthma shows efficacy and safety results. The study status is com…